Leukoaraiosis and high intraocular pressure are strongly associated with cardiovascular disease, vascular angiopathy, and geriatric syndrome. Until now, little is known about the relationship between ...

Optometrists, ophthalmologists and their patients will benefit from new, high-tech tools to detect glaucoma at its earliest stages thanks to a startup that will commercialize smart contact lenses ...

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for ...

As a fundamental component of the ocular examination, accurate measurement of intra-ocular pressure (IOP) facilitates the management of patients with established glaucoma and the identification of ...

Elevated or diminished eye pressure impairs our ability to see, and in the worst cases, can even lead to blindness. Until now, there has been no effective long-term treatment. In response, researchers ...

Shuchi Patel, MD: Good afternoon, Dr. Ruth Williams. Thank you so much for taking the time to have a discussion with us regarding a topic that is of emerging interest. Today we're going to talk about ...

A new device in the treatment of glaucoma has been introduced by Opthalmic Sciences. IOPerfect works by using artificial intelligence (AI) in a virtual reality-type headset which allows telediagnosis ...

In recent years, we've heard of at least two different implants designed to measure the intraocular pressure in glaucoma patients' eyes, potentially preventing blindness. Yet another such implant, ...

NDA submissions for NCX 470 are planned for the first half of 2026 in the US, with China following shortly after. NCX 470 is ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...